Pharmacy

Heritage Pharmaceuticals, a generic drugmaker in Eatontown, N.J., agreed to pay a settlement on May 31 to resolve allegations of to fix prices for its diabetes drug glyburide, the U.S. Justice Department said.

Disgraced former pharmaceutical company executive Martin Shkreli, currently serving a seven-year prison sentence for defrauding investors, has sued two directors and a former general counsel of Retrophin, the pharmaceutical company he founded, according to CNBC.

The FDA is launching a pilot project to make it easier for physicians to get unapproved cancer drugs for their patients, the agency announced June 3.

Two former pharmacists of a Massachusetts drug compounding center blamed for a meningitis outbreak described as the deadliest ever to be caused by a prescription drug, have been sentenced, according to The Tenneseean.

Geritrex, a private-label drugmaker, will close its production plant in Town of Wallkill, N.Y., resulting in 56 layoffs, according to the Times Herald-Record.

Seventeen top-selling brand-name drugs saw their prices more than double over a six-year period, according to a new study published in The Journal of the American Medical Association.

Johnson & Johnson was ordered by a jury to pay $300 million in punitive damages to a woman who claimed the company's talc-based products caused her asbestos-related cancer, according to CNBC.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Blink Health, an online discount pharmacy startup, has lowered prices for 148 of its most common generic drugs.

Merrimack Pharmaceuticals will lay off its entire staff, including its CEO and CFO, as operations continue to wind down over the next two months, according to Biospace.